Home › Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study
 

Keywords :   


Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study

2014-08-29 18:04:14| Agriculture - Topix.net

Senesco Technologies, Inc. today announced the closing of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T, a first-in-class modulator of eukaryotic translation initiation factor 5A , in patients with relapsed or refractory multiple myeloma, plasma cell leukemia or B cell lymphoma.

Tags: study phase closes enrollment

Category:Agriculture and Forestry

Latest from this category

All news
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11Iowa Select Farms fights food insecurity year-round
01.11Congress questions USDA on $45.6M in aid to bankrupt processor
01.11Sid Miller coy on ag secretary prospects
01.11Technology adoption: What's on the ag tech horizon for 2025
Agriculture and Forestry »
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
More »